UNITED THERAPEUTICS Corp reports

Location: Silver Spring, MD
Fiscal year end: 31 December

UNITED THERAPEUTICS Corp has filed 4,224 SEC EDGAR filings since 16 Apr 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page

25

Current page

40

4

4 filing

Filing date: 27 May 2022
Reporting date: 27 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 26 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 26 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 25 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 26 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 26 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 26 May 2022
Reporting date: 26 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 25 May 2022
Reporting date: 23 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26301

FORM 8-K

Filing date: 24 May 2022
Reporting date: 23 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 May 2022
Reporting date: 17 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 May 2022
Reporting date: 05 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 May 2022
Reporting date: 05 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26301

8-K

Filing date: 04 May 2022
Reporting date: 04 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-26301

10-Q

Filing date: 04 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 29 Apr 2022
Reporting date: 28 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-26301

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

Filing date: 29 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-26301

DEFINITIVE PROXY STATEMENT

Filing date: 29 Apr 2022
Reporting date: 27 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Apr 2022
Reporting date: 21 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Apr 2022
Reporting date: 21 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26301

FORM 8-K

Filing date: 22 Apr 2022
Reporting date: 21 Apr 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 15 Apr 2022
Reporting date: 14 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Apr 2022
Reporting date: 07 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Apr 2022
Reporting date: 07 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Apr 2022
Reporting date: 07 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .